Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

Clinical trial NCT06519994 · COMPLETED

Trial details

NCT number: NCT06519994
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Human Papillomavirus Cervical Precancer

Start date: 2025-01-22
Primary completion: 2026-04-08
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.